Invenomic Capital Management’s Belden BDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.27M Buy
+28,440
New +$3.58M 0.15% 115
2025
Q3
Sell
-53,944
Closed -$6.25M 147
2025
Q2
$6.25M Buy
+53,944
New +$5.67M 0.35% 87
2024
Q1
Sell
-57,537
Closed -$4.44M 152
2023
Q4
$4.44M Buy
+57,537
New +$4.28M 0.2% 114
2022
Q4
Sell
-117,440
Closed -$7.05M 144
2022
Q3
$7.05M Sell
117,440
-212,577
-64% -$13.5M 0.61% 55
2022
Q2
$17.6M Buy
330,017
+221,956
+205% +$11.9M 1.25% 19
2022
Q1
$4.91M Buy
108,061
+80,678
+295% +$4.64M 0.52% 62
2021
Q4
$1.8M Sell
27,383
-37,241
-58% -$2.34M 0.38% 78
2021
Q3
$3.77M Buy
64,624
+20,984
+48% +$1.12M 1.22% 27
2021
Q2
$2.21M Buy
+43,640
New +$2.13M 0.53% 43
2021
Q1
Sell
-58,528
Closed -$2.45M 123
2020
Q4
$2.45M Sell
58,528
-13,030
-18% -$481K 0.63% 30
2020
Q3
$2.23M Buy
71,558
+30,244
+73% +$997K 1.23% 26
2020
Q2
$1.34M Hold
41,314
0.99% 39
2020
Q1
$1.49M Sell
41,314
-51,422
-55% -$2.36M 1.22% 26
2019
Q4
$5.1M Buy
+92,736
New +$4.95M 2.05% 9

Other funds holding BDC

Invenomic Capital Management's BDC Position: Q1 2026 in Review

Invenomic Capital Management opened a new position in Belden (BDC) in Q1 2026: 28,440 shares worth $3.27M. The stake represents 0.15% of the portfolio and ranks #115 among its holdings. This is a return to the name: Invenomic Capital Management previously reported a position in BDC as recently as Q2 2025.

Invenomic Capital Management first reported a position in BDC in Q4 2019 and has held it in 14 quarters since. The position peaked at $17.6M in Q2 2022. 382 funds tracked by Wall St. Rank hold BDC as of Q1 2026.

  • Invenomic Capital Management held 28,440 shares of Belden worth $3.27M as of Q1 2026.
  • Belden was a new Invenomic Capital Management position in Q1 2026.
  • Belden made up 0.15% of Invenomic Capital Management's portfolio in Q1 2026, its #115 holding.
  • Invenomic Capital Management first reported a position in Belden in Q4 2019 and has held it in 14 quarters since.
  • Invenomic Capital Management's Belden position peaked at $17.6M in Q2 2022.
  • 382 funds tracked by Wall St. Rank held Belden as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.